Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Morice

Showing results (191-200 of 284) with videos related to

Pageof 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 22, 2018
Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume ParametersElena Manea, Alexandre Escande, Sophie Bockel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 13, 2015
Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experienceJulien Hadoux, Annie Rey, Pierre Duvillard, et al.
Bulletin Du Cancer|March 29, 2006
[Medical treatment of metastatic or recurrent cancer of the cervix]Thibault de la Motte Rouge, Patricia Pautier, Anne-Sophie Hamy, et al.
Virchows Archiv : an International Journal of Pathology|October 3, 2020
Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkersCatherine Genestie, Aurélie Auguste, Miriam Al Battal, et al.
International Journal of Radiation Oncology, Biology, Physics|August 16, 2023
Locoregional Treatment in Patients With Metastatic Cervical Cancer: Benefit of Dose Escalation StrategiesAdrien Laville, Kanta Ka, Radouane El-Ayachi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 30, 2018
Multimodal Management of Locally Advanced Neuroendocrine Cervical Carcinoma: A Single Institution ExperiencePauline Castelnau-Marchand, Patricia Pautier, Catherine Genestie, et al.
Annals of Surgical Oncology|August 24, 2007
Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavityYann Delpech, Christine Haie-Meder, Annie Rey, et al.
Journal of Clinical Medicine|June 5, 2020
Interaction between the Number of Chemotherapy Cycles and Brachytherapy Dose/Volume Parameters in Locally Advanced Cervical Cancer PatientsAlexandre Escande, Mohamed Khettab, Sophie Bockel, et al.
BMC Cancer|February 7, 2021
False negative rate at <sup>18</sup>F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technologySebastien Gouy, Veronika Seebacher, Cyrus Chargari, et al.
Annals of Surgical Oncology|June 3, 2015
Surgical Outcomes After Debulking Surgery for Intraabdominal Ovarian Growing Teratoma Syndrome: Analysis of 38 CasesEnrica Bentivegna, Henri Azaïs, Catherine Uzan, et al.
Pageof 29

Showing results (191-200 of 284) with videos related to

Sort By:
Pageof 29
International Journal of Radiation Oncology, Biology, Physics|March 22, 2018
Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume ParametersElena Manea, Alexandre Escande, Sophie Bockel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 13, 2015
Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experienceJulien Hadoux, Annie Rey, Pierre Duvillard, et al.
Bulletin Du Cancer|March 29, 2006
[Medical treatment of metastatic or recurrent cancer of the cervix]Thibault de la Motte Rouge, Patricia Pautier, Anne-Sophie Hamy, et al.
Virchows Archiv : an International Journal of Pathology|October 3, 2020
Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkersCatherine Genestie, Aurélie Auguste, Miriam Al Battal, et al.
International Journal of Radiation Oncology, Biology, Physics|August 16, 2023
Locoregional Treatment in Patients With Metastatic Cervical Cancer: Benefit of Dose Escalation StrategiesAdrien Laville, Kanta Ka, Radouane El-Ayachi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 30, 2018
Multimodal Management of Locally Advanced Neuroendocrine Cervical Carcinoma: A Single Institution ExperiencePauline Castelnau-Marchand, Patricia Pautier, Catherine Genestie, et al.
Annals of Surgical Oncology|August 24, 2007
Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavityYann Delpech, Christine Haie-Meder, Annie Rey, et al.
Journal of Clinical Medicine|June 5, 2020
Interaction between the Number of Chemotherapy Cycles and Brachytherapy Dose/Volume Parameters in Locally Advanced Cervical Cancer PatientsAlexandre Escande, Mohamed Khettab, Sophie Bockel, et al.
BMC Cancer|February 7, 2021
False negative rate at <sup>18</sup>F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technologySebastien Gouy, Veronika Seebacher, Cyrus Chargari, et al.
Annals of Surgical Oncology|June 3, 2015
Surgical Outcomes After Debulking Surgery for Intraabdominal Ovarian Growing Teratoma Syndrome: Analysis of 38 CasesEnrica Bentivegna, Henri Azaïs, Catherine Uzan, et al.
Pageof 29